Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma-Reference-Cited by-同舟云学术

Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma

Published:2009-11 Issue:8 Volume:14 Page:1156-1165
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:

Author:

OHTA Ken,MIYAMOTO Terumasa,AMAGASAKI Taro,YAMAMOTO Manabu,

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2009.01633.x/fullpdf

Reference22 articles.

1. Physico-chemical properties of human reaginic antibody IV. Presence of a unique immunoglobulin as a carrier of reaginic activity;Ishizaka;J. Immunol.,1966

2. The role of immunoglobulin E in allergy and asthma;Platts-Mills;Am. J. Respir. Crit. Care Med.,2001

3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J. Allergy Clin. Immunol.,2001

4. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics;Soler;Eur. Respir. J.,2001

5. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma;Holgate;Clin. Exp. Allergy,2004

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergic Alveoli's: The Lung's Immune Paradox in Hypersensitive Pneumonitis (EAA/HP);Iranian Journal of Pediatrics;2024-07-13

2. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials;European Respiratory Review;2024-04-24

3. Lung function trajectories in a cohort of patients with moderate‐to‐severe asthma on mepolizumab, omalizumab, or dupilumab;Allergy;2024-01-02

4. Effects of omalizumab on lung function in patients with moderate-to-severe allergic asthma: a systematic review and meta-analysis;Therapeutic Advances in Respiratory Disease;2024-01

5. Omalizumab: a quarter of a century in the fight against T2-inflammatory diseases of upper and lower respiratory tract;Meditsinskiy sovet = Medical Council;2023-11-16